Peter Gebhardt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peter Gebhardt has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bianca Hoffmann
Leibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Beutenbergstrasse 11a, Jena 07745, Germany
1 shared publication - Hans Peter Saluz
Department of Cell and Molecular Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany
1 shared publication - Ingo M Irmler
Institute of Immunology, Jena University Hospital, Leutragraben 3, Jena 07743, Germany
1 shared publication - Marc Thilo Figge
Applied Systems Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany
1 shared publication - Thomas Kamradt
Universitätsklinikum Jena
1 shared publication - Thomas Opfermann
Department of Nuclear Medicine, Jena University Hospital, Bachstrasse 18, Jena 07743, Germany
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 16 (4) , R155
18 F-Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis
Evaluation of disease severity in experimental models of rheumatoid arthritis is inevitably associated with assessment of structural bone damage. A noninvasive imaging technology allowing objective quantification of pathophysiological alterations of bone structure in rodents could substantially extend the methods used to date in preclinical arthritis research for staging of autoimmune disease severity or efficacy of therapeutical intervention. Sodium 18 F-fluoride (18 F-NaF) is a bone-seeking tracer well-suited for molecular imaging. Therefore, we systematically examined the use of 18 F-NaF positron emission tomography/computed tomography (PET/CT) in mice with glucose-6-phosphate isomerase (G6PI)–induced arthritis for quantification of pathological bone metabolism.
- 1 January 2014
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 16 (4) , R155
Open Access18 F-Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis
Evaluation of disease severity in experimental models of rheumatoid arthritis is inevitably associated with assessment of structural bone damage. A noninvasive imaging technology allowing objective quantification of pathophysiological alterations of bone structure in rodents could substantially extend the methods used to date in preclinical arthritis research for staging of autoimmune disease severity or efficacy of therapeutical intervention. Sodium 18 F-fluoride (18 F-NaF) is a bone-seeking tracer well-suited for molecular imaging. Therefore, we systematically examined the use of 18 F-NaF positron emission tomography/computed tomography (PET/CT) in mice with glucose-6-phosphate isomerase (G6PI)–induced arthritis for quantification of pathological bone metabolism.